Study of 0444 Gel in the Treatment of Inflammatory Lesions of Rosacea
Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
The aim of this trial is to assess the efficacy of Metronidazole Topical Gel 1% in the
Treatment of Inflammatory Lesions of Rosacea.
Treatment medication will be administered as follows: A thin film of gel will be applied and
rubbed into the entire face once daily for a period of 70 days.